Ezra’s mission is to enable early cancer detection for everyone by using Artificial Intelligence and the most advanced medical imaging technology available.

Of the 18.1 million¹ people who will be diagnosed with cancer this year, half will be diagnosed late². And here’s the really alarming news: patients who detect cancer late are much less likely to survive than those who find it early. We need to rethink the way we approach cancer screening.

We’re creating a new way to screen for prostate cancer, with other screening programs on the way.

Ultimately, our goal is to offer a whole-body MRI scan in a single session, and analyze it using the Ezra AI to quickly and accurately diagnose potential abnormalities anywhere in your body.

In addition to our MRI scans, we are also developing the Ezra AI technology that’s designed to make radiologists more accurate and more productive. The Ezra AI is an investigational device that has not received marketing authorization from the FDA, thus the safety and effectiveness of the device have not yet been established. After further study of our AI technology, we plan to seek FDA clearance and make the Ezra AI available to radiologists.